ArticleCancer science2018

Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.

Masaki Shiota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.